Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vertex Pharmaceuticals
Biotech
CRISPR Therapeutics laid off staff a week after positive AdComm
CRISPR Therapeutics laid off staff earlier this month despite being on the precipice of an FDA approval and having $1.7 billion in cash on hand.
Max Bayer
Nov 22, 2023 1:36pm
Vertex drops lung therapy, rethinks DMD drug's path to clinic
Nov 7, 2023 6:00am
FDA advisers wave through first CRISPR-based therapy
Nov 1, 2023 11:07am
CRISPR-Vertex gene editing 1st gets narrow review by FDA panel
Oct 27, 2023 11:20am
CRISPR on hunt for pipeline partners and enticing delivery tech
Oct 19, 2023 10:35am
Carl June, Vertex execs among 2024's Breakthrough Prize winners
Sep 15, 2023 8:00am